Literature DB >> 9703963

Merlin differs from moesin in binding to F-actin and in its intra- and intermolecular interactions.

L Huang1, E Ichimaru, K Pestonjamasp, X Cui, H Nakamura, G Y Lo, F I Lin, E J Luna, H Furthmayr.   

Abstract

The neurofibromatosis type 2 (NF2) tumor suppressor gene encodes merlin, a protein with homology to the cell membrane/F-actin linking proteins, moesin, ezrin and radixin. Unlike these closely related proteins, merlin lacks a C-terminal F-actin binding site detectable by actin blot overlays, and the GFP-tagged merlin C-terminal domain co-distributes with neither stress fibers nor cortical actin in NIH3T3 cells. Merlin also differs from the other three proteins in its inter- and intramolecular domain interactions, as shown by in vitro binding and yeast two-hybrid assays. As is true for ezrin, moesin and radixin, the N- and C-terminal domains of merlin type 1 bind to each other. However, full-length merlin and its N- and C-terminal domains, as well as the C-terminal domain of ezrin, interact with other full-length merlin type 1 molecules, and its C-terminal domain interacts with itself. Merlin 1 function in cells may thus depend on intra- and intermolecular interactions and their modulation, which include interactions with other members of this protein family.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9703963     DOI: 10.1006/bbrc.1998.9009

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Molecular analysis of microscopic ezrin dynamics by two-photon FRAP.

Authors:  Sylvie Coscoy; François Waharte; Alexis Gautreau; Marianne Martin; Daniel Louvard; Paul Mangeat; Monique Arpin; Françis Amblard
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

2.  The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.

Authors:  Anne-Marie Bashour; J-J Meng; Wallace Ip; Mia MacCollin; Nancy Ratner
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

3.  The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.

Authors:  H Morrison; L S Sherman; J Legg; F Banine; C Isacke; C A Haipek; D H Gutmann; H Ponta; P Herrlich
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

4.  The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association.

Authors:  M F James; N Manchanda; C Gonzalez-Agosti; J H Hartwig; V Ramesh
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

5.  Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins.

Authors:  L Goutebroze; E Brault; C Muchardt; J Camonis; G Thomas
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

6.  Binding of the merlin-I product of the neurofibromatosis type 2 tumour suppressor gene to a novel site in beta-fodrin is regulated by association between merlin domains.

Authors:  G W Neill; M R Crompton
Journal:  Biochem J       Date:  2001-09-15       Impact factor: 3.857

7.  Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma.

Authors:  Fabiana C Morales; Jennifer R Molina; Yuho Hayashi; Maria-Magdalena Georgescu
Journal:  Neuro Oncol       Date:  2010-02-14       Impact factor: 12.300

8.  The Na+/H+ Exchanger-3 (NHE3) Activity Requires Ezrin Binding to Phosphoinositide and Its Phosphorylation.

Authors:  Victor Babich; Francesca Di Sole
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

9.  Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity.

Authors:  Minja Laulajainen; Maria Melikova; Taru Muranen; Olli Carpén; Mikaela Grönholm
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

10.  Conformational flexibility determines the Nf2/merlin tumor suppressor functions.

Authors:  Marina C Primi; Erumbi S Rangarajan; Dipak N Patil; Tina Izard
Journal:  Matrix Biol Plus       Date:  2021-07-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.